CT Abdomen and Pelvis Without IV Contrast CT abdomen and pelvis without IV contrast for nodal staging is generally useful in high-risk patients because a priori risk of nodal disease exceeds 10% [20]. However, it should be recognized that without using IV contrast there is the possibility of less optimal detection of metastases to visceral organs. CT Chest, Abdomen, and Pelvis With IV Contrast CT chest, abdomen, and pelvis with IV contrast for nodal staging is generally useful in high-risk patients because a priori risk of nodal disease exceeds 10% [20]. CT Chest, Abdomen, and Pelvis Without and With IV Contrast There is limited evidence to support the use of CT chest, abdomen, and pelvis without and with IV contrast because obtaining CT with both techniques does not provide additional benefit in terms of detecting nodal and distant metastases. CT Chest, Abdomen, and Pelvis Without IV Contrast CT chest, abdomen, and pelvis without IV contrast for nodal staging is generally useful in high-risk patients because a priori risk of nodal disease exceeds 10% [20]. However, it should be recognized that without using IV contrast there is the possibility of less optimal detection of metastases to visceral organs. FDG-PET/CT Whole Body Because prostate cancer and metastases from it are generally not FDG-avid unlike most other malignancies, FDG- PET/CT may not be beneficial as part of staging clinically established high-risk prostate cancer. FDG-PET/MRI Skull Base to Mid-Thigh Because prostate cancer and metastases from it are generally not FDG-avid unlike most other malignancies, FDG- PET/MRI may not be beneficial as part of staging clinically established high-risk prostate cancer.
Pretreatment Detection Surveillance and Staging of Prostate Cancer. CT Abdomen and Pelvis Without IV Contrast CT abdomen and pelvis without IV contrast for nodal staging is generally useful in high-risk patients because a priori risk of nodal disease exceeds 10% [20]. However, it should be recognized that without using IV contrast there is the possibility of less optimal detection of metastases to visceral organs. CT Chest, Abdomen, and Pelvis With IV Contrast CT chest, abdomen, and pelvis with IV contrast for nodal staging is generally useful in high-risk patients because a priori risk of nodal disease exceeds 10% [20]. CT Chest, Abdomen, and Pelvis Without and With IV Contrast There is limited evidence to support the use of CT chest, abdomen, and pelvis without and with IV contrast because obtaining CT with both techniques does not provide additional benefit in terms of detecting nodal and distant metastases. CT Chest, Abdomen, and Pelvis Without IV Contrast CT chest, abdomen, and pelvis without IV contrast for nodal staging is generally useful in high-risk patients because a priori risk of nodal disease exceeds 10% [20]. However, it should be recognized that without using IV contrast there is the possibility of less optimal detection of metastases to visceral organs. FDG-PET/CT Whole Body Because prostate cancer and metastases from it are generally not FDG-avid unlike most other malignancies, FDG- PET/CT may not be beneficial as part of staging clinically established high-risk prostate cancer. FDG-PET/MRI Skull Base to Mid-Thigh Because prostate cancer and metastases from it are generally not FDG-avid unlike most other malignancies, FDG- PET/MRI may not be beneficial as part of staging clinically established high-risk prostate cancer.